PUM1 gene levels in sickle cell and beta-thalassemia
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at a gene called PUM1 in people with sickle cell anemia or beta-thalassemia intermedia. It may help scientists understand these conditions better, possibly leading to new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sickle cell anemia or beta-thalassemia intermedia.
- Both males and females of any age can join.
- You cannot have any other type of hemolytic anemia (a condition where red blood cells break down early).
- You cannot be taking hydroxyurea (a medicine sometimes used for sickle cell disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the activity of a gene called EKLF in people with beta-thalassemia, a blood disorder that causes low hemoglobin and anemia. By measuring this gene, researchers hope to better understand the condition and find ways to improve treatment.
This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.
This study tests an experimental gene therapy called YOLT-204 for people with sickle cell disease or thalassemia. It aims to see if the treatment is safe and can help reduce symptoms, and participants will be followed long-term.
This study looks at how a person’s genes relate to certain measurements in red blood cells in people with sickle cell disease. The goal is to understand why blood cell function varies and how that might guide future care.
This trial tests a new gene therapy for beta thalassemia. A modified virus is used to deliver a working gene to your blood stem cells, which may help your body produce normal hemoglobin and reduce the need for blood transfusions.
This study looks for a specific genetic change (in the KLF1 gene) in people with beta thalassemia. If found, it might help explain how the disease runs in families.
Hear when a new Sickle Cell Disease, Beta Thalassemia Intermedia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.